Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope

Bruce J. MacLachlan, Garry Dolton, Athanasios Papakyriakou, Alexander Greenshields-Watson, Georgina H. Mason, Andrea Schauenburg, Matthieu Besneux, Barbara Szomolay, Tim Elliott, Andrew K. Sewell, Awen Gallimore, Pierre Rizkallah, David K. Cole, Andrew Godkin

Open source

DOI: 10.1074/jbc.ra119.009437
Published: 2019-12
Container: Journal of Biological Chemistry
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1074/jbc.ra119.009437,
  title = {Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope},
  author = {Bruce J. MacLachlan and Garry Dolton and Athanasios Papakyriakou and Alexander Greenshields-Watson and Georgina H. Mason and Andrea Schauenburg and Matthieu Besneux and Barbara Szomolay and Tim Elliott and Andrew K. Sewell and Awen Gallimore and Pierre Rizkallah and David K. Cole and Andrew Godkin},
  year = {2019},
  journal = {Journal of Biological Chemistry},
  doi = {10.1074/jbc.ra119.009437},
  url = {https://doi.org/10.1074/jbc.ra119.009437}
}

RIS

TY  - JOUR
TI  - Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope
AU  - Bruce J. MacLachlan
AU  - Garry Dolton
AU  - Athanasios Papakyriakou
AU  - Alexander Greenshields-Watson
AU  - Georgina H. Mason
AU  - Andrea Schauenburg
AU  - Matthieu Besneux
AU  - Barbara Szomolay
AU  - Tim Elliott
AU  - Andrew K. Sewell
AU  - Awen Gallimore
AU  - Pierre Rizkallah
AU  - David K. Cole
AU  - Andrew Godkin
PY  - 2019
JO  - Journal of Biological Chemistry
DO  - 10.1074/jbc.ra119.009437
UR  - https://doi.org/10.1074/jbc.ra119.009437
ER  -

APA

MacLachlan, B. J., Dolton, G., Papakyriakou, A., Greenshields-Watson, A., Mason, G. H., Schauenburg, A., Besneux, M., Szomolay, B., Elliott, T., Sewell, A. K., Gallimore, A., Rizkallah, P., Cole, D. K., & Godkin, A. (2019). Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.ra119.009437

Source records

crossref · retrieved 2026-09-26T22:54:44.421Z